Caitong International Asset Management Co., LTD Enanta Pharmaceuticals Inc Transaction History

Caitong International Asset Management Co., LTD

$144 Billion
Q3 2025

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$4.26 - $7.95 $5,303 - $9,897	-1,245 Reduced 86.46%	195 $1.47 Million
Q1 2025 May 13, 2025	BUY	$4.82 - $8.49 $6,208 - $10,935	1,288 Added 847.37%	1,440 $7.95 Million
Q4 2024 Feb 14, 2025	BUY	$5.75 - $12.99 $874 - $1,974	152 New	152 $874,000

Others Institutions Holding ENTA

# of Institutions

128

Shares Held

19.4M

Call Options Held

290K

Put Options Held

61.7K

Farallon Capital Management LLC San Francisco, CA

2.12M
Shares

$25.6 Million
0.11% of portfolio
Krensavage Asset Management, LLC New York, NY

2.11M
Shares

$25.5 Million
10.78% of portfolio
Janus Henderson Group PLC London, X0

1.95M
Shares

$23.5 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.94M
Shares

$23.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$22.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $250M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.

Account